JESSECA IZQUIERDO: Open Payments
NPI 1962159616 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 61 payments from 12 companies in 2025. Trend: 2023 $849 · 2024 $1,586 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $267 |
| PFIZER INC. | 10 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $198 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $151 |
| Lilly USA, LLC | 1 | $122 |
| Madrigal Pharmaceuticals | 3 | $119 |
| Celltrion USA Inc. | 4 | $105 |
| Janssen Biotech, Inc. | 2 | $68 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
| GENZYME CORPORATION | 2 | $53 |
Products named: ENTYVIO, XELJANZ, OMVOH, REZDIFFRA, VEGZELMA, XIFAXAN, MAVYRET, CREON.
Industry payments across TX — which companies pay providers there.
